Retail News CRM

Tag: raises

  • Global Condom Shortage Looms as Leading Manufacturer Karex Bhd Raises Prices Amid Iran War Supply Chain Disruptions

    Global Condom Shortage Looms as Leading Manufacturer Karex Bhd Raises Prices Amid Iran War Supply Chain Disruptions

    Karex Bhd, the globally recognized top producer of condoms and supplier to major brands like Durex, has recently announced plans to increase prices by 20% to 30%. This price hike is a possible response to the ongoing supply chain disruptions, which could extend further depending on the duration of the Iran conflict.

    Increasing Demand and Costs

    The Malaysia-based company’s CEO, Goh Miah Kiat, shared that the current situation is precarious, with high prices being a significant concern. Goh stated that the company has no choice but to pass on these additional costs to the customers. An unexpected surge in demand for condoms, exacerbated by increased freight costs and shipping delays, has left many clients with unusually low stockpiles.

    Karex, the producer of over 5 billion condoms a year, supplies to leading brands like Trojan and Durex, as well as state health systems such as the NHS in Britain and the United Nations’ global aid programs.

    Supply Chain Bottlenecks

    The condom manufacturer is just one amongst numerous other companies, including medical glove makers, that are bracing themselves for supply chain bottlenecks. The ongoing conflict in Iran is straining energy and petrochemical flows from the Middle East, leading to procurement disruptions of raw materials.

    Since the commencement of the conflict in late February, Karex has witnessed cost increases for a variety of materials. These include synthetic rubber and nitrile used in condom manufacturing, packaging supplies, and lubricants such as aluminium foils and silicone oil.

    Boosting Output in Response to Rising Demand

    Despite these challenges, Karex has assured that it has sufficient supplies for the coming months. The company is also planning to increase output in response to the growing demand. The global stockpiles of condoms have witnessed a significant decrease following substantial spending cuts in foreign aid, particularly from the U.S. Agency for International Development in the previous year.

    Goh noted that demand for condoms has risen approximately 30% this year, with shipping disruptions further straining the supply. Shipments to areas like Europe and the United States now take almost two months to arrive, as compared to a month previously.

    Goh expressed concern over the high demand for condoms in developing countries where the local stock is insufficient due to extended product delivery times.

    Questions & Answers

    How much is Karex planning to raise its prices by?
    Karex has plans to increase its prices by 20% to 30% due to ongoing supply chain disruptions and rising operational costs.

    What has caused the rise in demand for condoms?
    The demand for condoms has surged due to rising freight costs and shipping delays which have resulted in lower stockpiles for many of Karex’s customers.

    How is the Iran conflict affecting Karex’s operations?
    The Iran conflict has strained the procurement of raw materials, leading to supply chain disruptions. This has caused a significant increase in the cost of materials like synthetic rubber, nitrile, packaging supplies, and lubricants which are essential in condom manufacturing.

  • Adidas Announces Record-breaking Third Quarter Revenue And Upgraded Full-year Profit Projection

    Adidas Announces Record-breaking Third Quarter Revenue And Upgraded Full-year Profit Projection

    Adidas, the renowned sportswear brand, recently announced a significant increase in their revenue for the third quarter. This surge was widespread, affecting all markets, categories, and channels.

    For the third quarter, the company’s total revenue skyrocketed to approximately €6.63 billion (US$7.7 billion), marking the highest third-quarter revenue ever for the company. This was primarily due to a 12% growth in the Adidas brand.

    The company pointed out that the impressive third-quarter results did not include revenue from Yeezy. This is because Adidas had successfully sold off the remainder of their Yeezy inventory at the end of the previous year.

    The gross margin for Adidas saw a slight but notable increase, improving by 0.5 percentage points to 51.8%. Additionally, the operating profit rose to €736 million, marking an increase from the €598 million recorded during the same period the previous year.

    Adidas’ CEO, Bjørn Gulden, expressed his pride in the company’s accomplishments during the third quarter. He mentioned, “Our teams delivered record revenues during a period of global volatility marked by tariff hikes in the US and widespread uncertainty among retailers and consumers. Despite these challenges, our brand and products continue to resonate well with consumers.”

    In light of these positive developments in the third quarter, Adidas has revised its full-year operating profit forecast. The company now expects its operating profit to increase to approximately €2 billion. This is a significant upgrade from their previous projection, which ranged between €1.7 billion and €1.8 billion.

    The improved forecast is a testament to the continuing momentum of the Adidas brand. It also acknowledges the company’s better-than-anticipated business performance and its successful efforts to partially offset the additional costs incurred due to increased US tariffs.

    As far as revenue is concerned, Adidas maintains its expectation of achieving double-digit currency-neutral growth for the year.

    Questions & Answers

    What was Adidas’ total revenue for the third quarter?
    Adidas reported a total third-quarter revenue of approximately €6.63 billion (US$7.7 billion), marking its highest ever for the quarter.

    What are the factors attributed to Adidas’ improved full-year operating profit outlook?
    The revised outlook reflects the continuous momentum of the Adidas brand, better-than-expected business performance, and the company’s successful efforts to partially offset additional costs due to increased US tariffs.

    What is Adidas’ expectation for revenue growth for the year?
    Adidas continues to expect double-digit currency-neutral growth for the year’s revenue.

  • Sigma Healthcare Resets Merger Synergy Target With Chemist Warehouse Amidst Significant Revenue Surge

    Sigma Healthcare Resets Merger Synergy Target With Chemist Warehouse Amidst Significant Revenue Surge

    Sigma Healthcare has revised its merger synergy target with Chemist Warehouse, following a significant increase in both its top and bottom line results last year.

    New Merger Synergy Targets

    Sigma Healthcare has now set its synergy target for the merger at $100 million per annum, a substantial increase from the previous target of $60 million. The company aims to attain this goal within a span of four years.

    The last fiscal year ending June 30 saw an 82.2 per cent surge in revenue to $6 billion. Chemist Warehouse reported a 14 per cent increase in retail network sales, and a notable 11.3 per cent rise in like-for-like sales across the Australian network.

    Brand Expansion and Financial Performance

    Over the past year, Sigma increased its portfolio of proprietary and exclusive brand products, with a notable release of 269 products in the Wagner generics range last November. The sales of proprietary and exclusive label products saw an increase of over 20 per cent.

    When it comes to the bottom line, statutory earnings before interest, taxes, depreciation, and amortization (EBITDA) increased by 33.6 per cent to $824 million, while the net profit after tax (NPAT) reported a slight decline of 2.1 per cent to $530 million. However, normalized EBITDA saw a rise of 41.4 per cent to $884 million, and NPAT also increased by 40.1 per cent to $579 million.

    By June 30, the net debt stood at $752 million, significantly lower than the initial net debt range of $1 billion to $1.3 billion as indicated in the merger prospectus.

    Anticipated Growth and Future Plans

    Sigma CEO and MD, Vikesh Ramsunder, stated that the merger with Chemist Warehouse has resulted in a more robust, integrated healthcare business with enhanced scale, capability, and market reach. He emphasized that the FY25 results highlight the group’s momentum and potential for sustained growth.

    As part of its plan for the new fiscal year, Sigma intends to continue the expansion of Chemist Warehouse stores both domestically and internationally at a steady pace. It also plans to introduce new proprietary and exclusive label products to enhance margins.

    Sigma also announced the closure of distribution centres in South Guildford, WA, and Port Adelaide, SA, with services being moved to existing centres in Canning Vale and Pooraka. The company also plans to gradually close brick-and-mortar Chemist Warehouse stores in China over the next few years, focusing on achieving profitable growth, with the Chinese market being serviced through online channels thereafter.

    Questions & Answers

    What is the new merger synergy target set by Sigma Healthcare?
    The new merger synergy target set by Sigma Healthcare is $100 million per annum, up from the previous target of $60 million.

    What are Sigma Healthcare’s plans for the new fiscal year?
    Sigma plans to expand Chemist Warehouse stores in Australia and internationally, launch new proprietary and exclusive label products, and shift services from closing distribution centres to existing ones.

    What is Sigma Healthcare’s strategy for the Chinese market?
    Sigma Healthcare plans to gradually close Chemist Warehouse physical stores in China over the next few years, focusing on servicing the Chinese market through online channels.